The global kidney cancer diagnostic and therapeutic market are growing at a considerable CAGR of 6.8% during the forecast period. The key features that drive the market growth include, increasing prevalence of kidney cancer, change in lifestyles such as smoking and drinking, less physical activity, and endorsement of novel drugs for the treatment of kidney cancer are the main factors driving...